Concepedia

Author

MV Blagosklonny

National Cancer Institute

Also Known As

MV Blagosklonny

12

Publications

903

Citations

10

H-Index

36

Concepts

All Affiliations

National Cancer InstituteNational Institutes of Health
MB

About

MV Blagosklonny is an author at National Cancer Institute specializing in medicine, pharmacology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

363

2

Cell Biology

4

4

264

3

Education

1

1

11

4

Public Health

1

1

11

5

Geriatrics

1

1

11

MV Blagosklonny

×

6

Publications

363

Citations

6

H-Index

YearCitations

The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy

MV Blagosklonny, Tito Fojo, J-S Kim,

Leukemia

2001

123

Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells

MV Blagosklonny

Leukemia

2001

88

Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells

MV Blagosklonny, Yoshiro Chuman, Tito Fojo

Leukemia

1999

73

Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal

MV Blagosklonny

Leukemia

1999

39

Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells

Edward Kyle, Sajni Patel, Franck Housseau,

Prostate Cancer and Prostatic Diseases

2001

29

Impact papers on aging in 2009 - eScholarship

MV Blagosklonny, Judith Campisi, DA Sinclair,

2010

11

Page 1